drugset / Trial / NCT06982196

Sulodexide in Controlling the Recurrence of Psoriasis

NCT06982196

Phase 3 Enrolling by invitation 160 enrolled Xijing Hospital
RandomizedParallel-groupQuadruple-blindPrevention

Summary

This is a multicenter, randomized, double-blinded,controlled clinical trial. The purpose of the study is to evaluate the efficacy and safety of Sulodexide versus placebo in preventing psoriasis recurrence in patients with plaque psoriasis who have discontinued biologic therapy after achieving clinical cure.

Timeline

Start
2025-04-20
Primary completion
2026-06-30
Completion
2027-12-31

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Sulodexide Other / unclassified 250 unknown Oral

Indications